| Year |
Citation |
Score |
| 2024 |
Regunath K, Fomin V, Wang P, Liu Z, Hoque M, Tian B, Rabadan R, Prives C. Systematic characterization of p53-regulated long non-coding RNAs across human cancers reveals remarkable heterogeneity among different tumor types. Molecular Cancer Research : McR. PMID 38393317 DOI: 10.1158/1541-7786.MCR-23-0295 |
0.385 |
|
| 2024 |
Low-Calle AM, Ghoneima H, Ortega N, Cuibus AM, Katz C, Prives C, Prywes R. A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63. Molecular and Cellular Biology. 1-16. PMID 38270135 DOI: 10.1080/10985549.2023.2292037 |
0.422 |
|
| 2023 |
Efe G, Dunbar KJ, Sugiura K, Cunningham K, Carcamo S, Karaiskos S, Tang Q, Cruz-Acuna R, Resnick-Silverman L, Peura J, Lu C, Hasson D, Klein-Szanto AJ, Taylor AM, Manfredi JJ, ... Prives C, et al. p53 gain-of-function mutation induces metastasis via Brd4-dependent Csf-1 expression. Cancer Discovery. PMID 37676642 DOI: 10.1158/2159-8290.CD-23-0601 |
0.354 |
|
| 2023 |
Choe JH, Kawase T, Xu A, Guzman A, Obradovic AZ, Low-Calle AM, Alaghebandan B, Raghavan A, Long K, Hwang PM, Schiffman JD, Zhu Y, Zhao R, Lee DF, Katz C, ... Prives C, et al. Li-Fraumeni Syndrome-Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death. Cancer Discovery. OF1-OF24. PMID 37067901 DOI: 10.1158/2159-8290.CD-22-0882 |
0.505 |
|
| 2023 |
Low-Calle AM, Ghoneima H, Ortega N, Cuibus AM, Katz C, Tong D, Prives C, Prywes R. A non-canonical Hippo pathway represses the expression of ΔNp63. Biorxiv : the Preprint Server For Biology. PMID 36824867 DOI: 10.1101/2023.02.13.528336 |
0.435 |
|
| 2022 |
de Queiroz RM, Moon SH, Prives C. O-GlcNAc transferase regulates p21 protein levels and cell proliferation through the FoxM1-Skp2 axis in a p53-independent manner. The Journal of Biological Chemistry. 298: 102289. PMID 35868563 DOI: 10.1016/j.jbc.2022.102289 |
0.548 |
|
| 2021 |
Klein AM, Biderman L, Tong D, Alaghebandan B, Plumber SA, Mueller HS, van Vlimmeren A, Katz C, Prives C. MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34716260 DOI: 10.1073/pnas.2102420118 |
0.871 |
|
| 2021 |
Ellison V, Annor GK, Freedman C, Xiao G, Lundine D, Freulich E, Prives C, Bargonetti J. Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity. Oncotarget. 12: 1128-1146. PMID 34136083 DOI: 10.18632/oncotarget.27975 |
0.411 |
|
| 2021 |
Tong DR, Zhou W, Katz C, Regunath K, Venkatesh D, Ihuegbu C, Manfredi JJ, Laptenko O, Prives C. p53 frameshift mutations couple loss-of-function with unique neomorphic activities. Molecular Cancer Research : McR. PMID 34045312 DOI: 10.1158/1541-7786.MCR-20-0691 |
0.5 |
|
| 2021 |
Klein AM, de Queiroz RM, Venkatesh D, Prives C. The roles and regulation of MDM2 and MDMX: it is not just about p53. Genes & Development. 35: 575-601. PMID 33888565 DOI: 10.1101/gad.347872.120 |
0.501 |
|
| 2020 |
Venkatesh D, Stockwell BR, Prives C. p21 can be a barrier to ferroptosis independent of p53. Aging. 12: 17800-17814. PMID 32979260 DOI: 10.18632/aging.103961 |
0.494 |
|
| 2020 |
Venkatesh D, O'Brien NA, Zandkarimi F, Tong DR, Stokes ME, Dunn DE, Kengmana ES, Aron AT, Klein AM, Csuka JM, Moon SH, Conrad M, Chang CJ, Lo DC, D'Alessandro A, ... Prives C, et al. MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling. Genes & Development. PMID 32079652 DOI: 10.1101/Gad.334219.119 |
0.536 |
|
| 2020 |
Nikolaev A, Tong D, Xing C, Zeng L, Prives C, Bonner J, Yang E. Pharmacological Targeting Of Mutant p53 Gain-of-Function Represses Mevalonate Pathway Of Cholesterol Biosynthesis And Sensitizes Tumor Cells To Radiation International Journal of Radiation Oncology*Biology*Physics. 108: e562. DOI: 10.1016/j.ijrobp.2020.07.1739 |
0.319 |
|
| 2019 |
Bargonetti J, Prives C. Gain-of-function mutant p53: history and speculation. Journal of Molecular Cell Biology. 11: 605-609. PMID 31283823 DOI: 10.1093/Jmcb/Mjz067 |
0.465 |
|
| 2018 |
Moon SH, Huang CH, Houlihan SL, Regunath K, Freed-Pastor WA, Morris JP, Tschaharganeh DF, Kastenhuber ER, Barsotti AM, Culp-Hill R, Xue W, Ho YJ, Baslan T, Li X, Mayle A, ... ... Prives C, et al. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression. Cell. PMID 30580964 DOI: 10.1016/J.Cell.2018.11.011 |
0.854 |
|
| 2018 |
Muniz de Queiroz R, Prives C. Unfolding the roles of resveratrol in p53 regulation. Oncotarget. 9: 34455-34456. PMID 30349639 DOI: 10.18632/Oncotarget.26185 |
0.559 |
|
| 2018 |
Fomin V, Richard P, Hoque M, Li C, Gu Z, Fissore-O'Leary M, Tian B, Prives C, Manley JL. The gene, implicated in ALS/FTD, encodes a protein that functions in control of endothelin and glutamate signaling. Molecular and Cellular Biology. PMID 30150298 DOI: 10.1128/Mcb.00155-18 |
0.315 |
|
| 2018 |
Karni-Schmidt O, Friedler A, Zupnick A, McKinney K, Mattia M, Beckerman R, Bouvet P, Sheetz M, Fersht A, Prives C. Correction: Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus. Oncogene. 37: 4901-4902. PMID 30068941 DOI: 10.1038/s41388-018-0321-1 |
0.794 |
|
| 2018 |
Rokudai S, Li Y, Otaka Y, Fujieda M, Owens DM, Christiano AM, Nishiyama M, Prives C. STXBP4 regulates APC/C-mediated p63 turnover and drives squamous cell carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America. PMID 29735662 DOI: 10.1073/Pnas.1718546115 |
0.507 |
|
| 2018 |
Rastogi C, Rube HT, Kribelbauer JF, Crocker J, Loker RE, Martini GD, Laptenko O, Freed-Pastor WA, Prives C, Stern DL, Mann RS, Bussemaker HJ. Accurate and sensitive quantification of protein-DNA binding affinity. Proceedings of the National Academy of Sciences of the United States of America. PMID 29610332 DOI: 10.1073/Pnas.1714376115 |
0.775 |
|
| 2018 |
Katz C, Low-Calle AM, Choe J, Laptenko O, Tong D, Joseph-Chowdhury JN, Garofalo F, Zhu Y, Friedler A, Prives C. Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers. Genes & Development. PMID 29549180 DOI: 10.1101/Gad.304071.117 |
0.641 |
|
| 2018 |
Wu D, Prives C. Relevance of the p53-MDM2 axis to aging. Cell Death & Differentiation. 25: 169-179. PMID 29192902 DOI: 10.1038/Cdd.2017.187 |
0.498 |
|
| 2017 |
Lessel D, Wu D, Trujillo C, Ramezani T, Lessel I, Alwasiyah MK, Saha B, Hisama FM, Rading K, Goebel I, Schütz P, Speit G, Högel J, Thiele H, Nürnberg G, ... ... Prives C, et al. Dysfunction of the MDM2/p53 axis is linked to premature aging. The Journal of Clinical Investigation. PMID 28846075 DOI: 10.1172/Jci92171 |
0.562 |
|
| 2017 |
Laptenko O, Prives C. p53: master of life, death, and the epigenome. Genes & Development. 31: 955-956. PMID 28637690 DOI: 10.1101/Gad.302364.117 |
0.508 |
|
| 2017 |
Kribelbauer JF, Laptenko O, Chen S, Martini GD, Freed-Pastor WA, Prives C, Mann RS, Bussemaker HJ. Quantitative Analysis of the DNA Methylation Sensitivity of Transcription Factor Complexes. Cell Reports. 19: 2383-2395. PMID 28614722 DOI: 10.1016/J.Celrep.2017.05.069 |
0.798 |
|
| 2017 |
Otaka Y, Rokudai S, Kaira K, Fujieda M, Horikoshi I, Iwakawa-Kawabata R, Yoshiyama S, Yokobori T, Ohtaki Y, Shimizu K, Oyama T, Tamura J, Prives C, Nishiyama M. STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell Carcinoma. Clinical Cancer Research. 23: 3442-3452. PMID 28087642 DOI: 10.1158/1078-0432.Ccr-16-1815 |
0.33 |
|
| 2017 |
Pfister NT, Prives C. Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53. Cold Spring Harbor Perspectives in Medicine. 7. PMID 27836911 DOI: 10.1101/Cshperspect.A026054 |
0.542 |
|
| 2017 |
Freed-Pastor W, Prives C. Targeting mutant p53 through the mevalonate pathway. Nature Cell Biology. 18: 1122-1124. PMID 27784901 DOI: 10.1038/Ncb3435 |
0.835 |
|
| 2016 |
Yoh KE, Regunath K, Guzman A, Lee SM, Pfister NT, Akanni O, Kaufman LJ, Prives C, Prywes R. Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 27681615 DOI: 10.1073/Pnas.1613417113 |
0.44 |
|
| 2016 |
Laptenko O, Tong DR, Manfredi J, Prives C. The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein. Trends in Biochemical Sciences. PMID 27669647 DOI: 10.1016/J.Tibs.2016.08.011 |
0.583 |
|
| 2016 |
Beckerman R, Yoh K, Mattia-Sansobrino M, Zupnick A, Laptenko O, Karni-Schmidt O, Ahn J, Byeon IJ, Keezer S, Prives C. Lysines in the tetramerization domain of p53 selectively modulate G1 arrest. Cell Cycle (Georgetown, Tex.). 1-14. PMID 27210019 DOI: 10.1080/15384101.2016.1170270 |
0.865 |
|
| 2016 |
Pfister NT, Prives C. Chromatin dysregulation by mutant p53 Oncotarget. 7: 29875-29876. PMID 27127877 DOI: 10.18632/Oncotarget.7922 |
0.617 |
|
| 2016 |
Karni-Schmidt O, Lokshin M, Prives C. The Roles of MDM2 and MDMX in Cancer. Annual Review of Pathology. PMID 27022975 DOI: 10.1146/Annurev-Pathol-012414-040349 |
0.819 |
|
| 2015 |
Prives C, Lowe SW. Cancer: Mutant p53 and chromatin regulation. Nature. 525: 199-200. PMID 26331537 DOI: 10.1038/Nature15212 |
0.559 |
|
| 2015 |
Pfister NT, Fomin V, Regunath K, Zhou JY, Zhou W, Silwal-Pandit L, Freed-Pastor WA, Laptenko O, Neo SP, Bargonetti J, Hoque M, Tian B, Gunaratne J, Engebraaten O, Manley JL, ... ... Prives C, et al. Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells. Genes & Development. 29: 1298-315. PMID 26080815 DOI: 10.1101/Gad.263202.115 |
0.831 |
|
| 2015 |
Laptenko O, Shiff I, Freed-Pastor W, Zupnick A, Mattia M, Freulich E, Shamir I, Kadouri N, Kahan T, Manfredi J, Simon I, Prives C. The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain. Molecular Cell. 57: 1034-46. PMID 25794615 DOI: 10.1016/J.Molcel.2015.02.015 |
0.826 |
|
| 2015 |
Otaka Y, Rokudai S, Kaira K, Shimizu K, Ito M, Ichihara A, Kawabata R, Yoshiyama S, Yamane A, Asao T, Prives C, Nishiyama M. Abstract 2070: Stxbp4 suppresses APC/C mediated turnover of p63 and increases tumorigenicity and malignancy Cancer Research. 75: 2070-2070. DOI: 10.1158/1538-7445.Am2015-2070 |
0.496 |
|
| 2015 |
Prives C. p53 with a Human Touch Cell. 162: 463-464. DOI: 10.1016/J.Cell.2015.07.029 |
0.525 |
|
| 2014 |
Pfister NT, Yoh KE, Prives C. p53, DNA damage, and NAD+ homeostasis. Cell Cycle. 13: 1661-1662. PMID 24810733 DOI: 10.4161/Cc.29151 |
0.639 |
|
| 2014 |
Weissmueller S, Manchado E, Saborowski M, Morris JP, Wagenblast E, Davis CA, Moon SH, Pfister NT, Tschaharganeh DF, Kitzing T, Aust D, Markert EK, Wu J, Grimmond SM, Pilarsky C, ... Prives C, et al. Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling. Cell. 157: 382-94. PMID 24725405 DOI: 10.1016/J.Cell.2014.01.066 |
0.519 |
|
| 2014 |
Prives CL. Abstract PL01-02: The two faces of p53: Tumor suppressor and oncogene Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Pl01-02 |
0.61 |
|
| 2014 |
Poyurovsky MV, Prives C. P53: Guardian of the metabolome P53 in the Clinics. 47-64. DOI: 10.1007/978-1-4614-3676-8_3 |
0.725 |
|
| 2013 |
Zhu Y, Regunath K, Jacq X, Prives C. Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry Genes & Development. 27: 1739-1751. PMID 23934659 DOI: 10.1101/Gad.212258.112 |
0.56 |
|
| 2013 |
Daftuar L, Zhu Y, Jacq X, Prives C. Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. Plos One. 8: e68667. PMID 23874713 DOI: 10.1371/Journal.Pone.0068667 |
0.634 |
|
| 2013 |
Mansilla SF, Soria G, Vallerga MB, Habif M, Martínez-López W, Prives C, Gottifredi V. UV-triggered p21 degradation facilitates damaged-DNA replication and preserves genomic stability. Nucleic Acids Research. 41: 6942-51. PMID 23723248 DOI: 10.1093/nar/gkt475 |
0.474 |
|
| 2013 |
Laptenko O, Prives C. Anything but Simple: A Phosphorylation-Driven Toggle within Brd4 Triggers Gene-Specific Transcriptional Activation Molecular Cell. 49: 838-839. PMID 23473602 DOI: 10.1016/J.Molcel.2013.02.021 |
0.302 |
|
| 2013 |
Rokudai S, Laptenko O, Arnal SM, Taya Y, Kitabayashi I, Prives C. MOZ increases p53 acetylation and premature senescence through its complex formation with PML Proceedings of the National Academy of Sciences of the United States of America. 110: 3895-3900. PMID 23431171 DOI: 10.1073/Pnas.1300490110 |
0.607 |
|
| 2013 |
Moon S, Prives CL. Mutant p53 succumbs to starvation. Cell Cycle. 12: 867-867. PMID 23421997 DOI: 10.4161/Cc.23911 |
0.605 |
|
| 2012 |
Bursać S, Brdovčak MC, Pfannkuchen M, Orsolić I, Golomb L, Zhu Y, Katz C, Daftuar L, Grabušić K, Vukelić I, Filić V, Oren M, Prives C, Volarevic S. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proceedings of the National Academy of Sciences of the United States of America. 109: 20467-72. PMID 23169665 DOI: 10.1073/Pnas.1218535109 |
0.37 |
|
| 2012 |
Biderman L, Manley JL, Prives C. Mdm2 and MdmX as Regulators of Gene Expression. Genes & Cancer. 3: 264-73. PMID 23150759 DOI: 10.1177/1947601912455331 |
0.85 |
|
| 2012 |
Singer S, Zhao R, Barsotti AM, Ouwehand A, Fazollahi M, Coutavas E, Breuhahn K, Neumann O, Longerich T, Pusterla T, Powers MA, Giles KM, Leedman PJ, Hess J, Grunwald D, ... ... Prives C, et al. Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes. Molecular Cell. 48: 799-810. PMID 23102701 DOI: 10.1016/J.Molcel.2012.09.020 |
0.843 |
|
| 2012 |
Laptenko O, Prives C. The p53-HAT connection: PCAF rules? Cell Cycle. 11: 2975-2975. PMID 22889733 DOI: 10.4161/Cc.21528 |
0.63 |
|
| 2012 |
Freed-Pastor WA, Prives C. Mutant p53: one name, many proteins. Genes & Development. 26: 1268-86. PMID 22713868 DOI: 10.1101/Gad.190678.112 |
0.838 |
|
| 2012 |
Biderman L, Poyurovsky MV, Assia Y, Manley JL, Prives C. MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress. Molecular and Cellular Biology. 32: 1214-25. PMID 22290440 DOI: 10.1128/Mcb.06150-11 |
0.88 |
|
| 2012 |
Freed-Pastor WA, Mizuno H, Zhao X, Langerød A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li W, Polotskaia A, Bissell MJ, Osborne TF, Tian B, Lowe SW, Silva JM, ... ... Prives C, et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell. 148: 244-58. PMID 22265415 DOI: 10.1016/J.Cell.2011.12.017 |
0.838 |
|
| 2012 |
Barsotti AM, Beckerman R, Laptenko O, Huppi K, Caplen NJ, Prives C. p53-Dependent induction of PVT1 and miR-1204. The Journal of Biological Chemistry. 287: 2509-19. PMID 22110125 DOI: 10.1074/Jbc.M111.322875 |
0.804 |
|
| 2012 |
Singer S, Barsotti A, Fazollahi M, Ouwehand A, Grünwald D, Breuhahn K, Bussemaker H, Singer R, Schirmacher P, Prives C. A nuclear pore component regulates select p53 target genes Zeitschrift FüR Gastroenterologie. 50. DOI: 10.1055/S-0031-1296009 |
0.331 |
|
| 2011 |
Herman AG, Hayano M, Poyurovsky MV, Shimada K, Skouta R, Prives C, Stockwell BR. Discovery of Mdm2-MdmX E3 ligase inhibitors using a cell-based ubiquitination assay. Cancer Discovery. 1: 312-25. PMID 22586610 DOI: 10.1158/2159-8290.Cd-11-0104 |
0.736 |
|
| 2011 |
Freed-Pastor WA, Prives C. Dissimilar DNA binding by p53 in normal and tumor-derived cells. Cell Cycle (Georgetown, Tex.). 10: 4207. PMID 22127203 DOI: 10.4161/Cc.10.24.18723 |
0.819 |
|
| 2011 |
Sasaki M, Kawahara K, Nishio M, Mimori K, Kogo R, Hamada K, Itoh B, Wang J, Komatsu Y, Yang YR, Hikasa H, Horie Y, Yamashita T, Kamijo T, Zhang Y, ... ... Prives C, et al. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nature Medicine. 17: 944-51. PMID 21804542 DOI: 10.1038/Nm.2392 |
0.573 |
|
| 2011 |
Huggins P, Zhong S, Shiff I, Beckerman R, Laptenko O, Prives C, Schulz MH, Simon I, Bar-Joseph Z. DECOD: fast and accurate discriminative DNA motif finding. Bioinformatics (Oxford, England). 27: 2361-7. PMID 21752801 DOI: 10.1093/Bioinformatics/Btr412 |
0.69 |
|
| 2011 |
Laptenko O, Beckerman R, Freulich E, Prives C. p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America. 108: 10385-90. PMID 21606339 DOI: 10.1073/Pnas.1105680108 |
0.855 |
|
| 2011 |
Karni-Schmidt O, Castillo-Martin M, Shen TH, HuaiShen T, Gladoun N, Domingo-Domenech J, Sanchez-Carbayo M, Li Y, Lowe S, Prives C, Cordon-Cardo C. Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. The American Journal of Pathology. 178: 1350-60. PMID 21356385 DOI: 10.1016/J.Ajpath.2010.11.061 |
0.831 |
|
| 2011 |
Poyurovsky MV, Katz C, Laptenko O, Beckerman R, Lokshin M, Ahn J, Byeon IL, Gabizon R, Mattia M, Zupnick A, Brown LM, Friedler A, Prives C. Erratum: The C terminus of p53 binds the N-terminal domain of MDM2 Nature Structural & Molecular Biology. 18: 516-516. DOI: 10.1038/Nsmb0411-516C |
0.776 |
|
| 2010 |
Daftuar L, Zhu Y, Prives C. Ribosomal protein L37 and the p53 network. Cell Cycle (Georgetown, Tex.). 9: 4259. PMID 21057197 DOI: 10.4161/Cc.9.21.13527 |
0.384 |
|
| 2010 |
Peart MJ, Poyurovsky MV, Kass EM, Urist M, Verschuren EW, Summers MK, Jackson PK, Prives C. APC/C(Cdc20) targets E2F1 for degradation in prometaphase. Cell Cycle (Georgetown, Tex.). 9: 3956-64. PMID 20948288 DOI: 10.4161/Cc.9.19.13162 |
0.813 |
|
| 2010 |
Barsotti AM, Prives C. Noncoding RNAs: the missing "linc" in p53-mediated repression. Cell. 142: 358-60. PMID 20691894 DOI: 10.1016/J.Cell.2010.07.029 |
0.819 |
|
| 2010 |
Beckerman R, Prives C. Transcriptional regulation by p53. Cold Spring Harbor Perspectives in Biology. 2: a000935. PMID 20679336 DOI: 10.1101/Cshperspect.A000935 |
0.831 |
|
| 2010 |
Priest C, Prives C, Poyurovsky MV. Deconstructing nucleotide binding activity of the Mdm2 RING domain Nucleic Acids Research. 38: 7587-7598. PMID 20671028 DOI: 10.1093/Nar/Gkq669 |
0.745 |
|
| 2010 |
Poyurovsky MV, Prives C. P53 and aging: A fresh look at an old paradigm. Aging. 2: 380-2. PMID 20657036 DOI: 10.18632/AGING.100179 |
0.636 |
|
| 2010 |
Poyurovsky MV, Katz C, Laptenko O, Beckerman R, Lokshin M, Ahn J, Byeon IJ, Gabizon R, Mattia M, Zupnick A, Brown LM, Friedler A, Prives C. The C terminus of p53 binds the N-terminal domain of MDM2. Nature Structural & Molecular Biology. 17: 982-9. PMID 20639885 DOI: 10.1038/Nsmb.1872 |
0.85 |
|
| 2010 |
Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, Lokshin M, Hosokawa H, Nakayama T, Suzuki Y, Sugano S, Sato E, Nagao T, Yokote K, Tatsuno I, ... Prives C, et al. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America. 107: 7461-6. PMID 20351271 DOI: 10.1073/Pnas.1002459107 |
0.812 |
|
| 2010 |
Prives C, Barsotti AM, Beckerman R, Biderman L, Laptenko O, Mattia M, Tanaka T, Singer S, Zupnick A. 636 Mechanisms by which the p53 tumour suppressor protein selects its target genes Ejc Supplements. 8: 161. DOI: 10.1016/S1359-6349(10)71436-1 |
0.818 |
|
| 2009 |
Zhu Y, Prives C. p53 and Metabolism: The GAMT Connection Molecular Cell. 36: 351-352. PMID 19917243 DOI: 10.1016/J.Molcel.2009.10.026 |
0.367 |
|
| 2009 |
Barsotti AM, Prives C. Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene. 28: 4295-305. PMID 19749794 DOI: 10.1038/Onc.2009.282 |
0.871 |
|
| 2009 |
Harris CR, Dewan A, Zupnick A, Normart R, Gabriel A, Prives C, Levine AJ, Hoh J. p53 responsive elements in human retrotransposons. Oncogene. 28: 3857-65. PMID 19718052 DOI: 10.1038/Onc.2009.246 |
0.821 |
|
| 2009 |
Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, Jacq X, Prives C. Ribosomal protein S7 is both a regulator and a substrate of MDM2. Molecular Cell. 35: 316-26. PMID 19683495 DOI: 10.1016/J.Molcel.2009.07.014 |
0.83 |
|
| 2009 |
Tsvetkov P, Reuven N, Prives C, Shaul Y. Susceptibility of p53 unstructured N terminus to 20 S proteasomal degradation programs the stress response. The Journal of Biological Chemistry. 284: 26234-42. PMID 19617345 DOI: 10.1074/Jbc.M109.040493 |
0.495 |
|
| 2009 |
Beckerman R, Donner AJ, Mattia M, Peart MJ, Manley JL, Espinosa JM, Prives C. A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint. Genes & Development. 23: 1364-77. PMID 19487575 DOI: 10.1101/Gad.1795709 |
0.857 |
|
| 2009 |
Ahn J, Poyurovsky MV, Baptiste N, Beckerman R, Cain C, Mattia M, McKinney K, Zhou J, Zupnick A, Gottifredi V, Prives C. Dissection of the sequence-specific DNA binding and exonuclease activities reveals a superactive yet apoptotically impaired mutant p53 protein. Cell Cycle (Georgetown, Tex.). 8: 1603-15. PMID 19462533 DOI: 10.4161/Cc.8.10.8548 |
0.829 |
|
| 2009 |
Li Y, Peart MJ, Prives C. Stxbp4 Regulates ΔNp63 Stability by Suppression of RACK1-Dependent Degradation Molecular and Cellular Biology. 29: 3953-3963. PMID 19451233 DOI: 10.1128/Mcb.00449-09 |
0.53 |
|
| 2009 |
Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53 Cell. 137: 413-431. PMID 19410540 DOI: 10.1016/J.Cell.2009.04.037 |
0.595 |
|
| 2009 |
Kass EM, Poyurovsky MV, Zhu Y, Prives C. Mdm2 and PCAF increase Chk2 ubiquitination and degradation independently of their intrinsic E3 ligase activities. Cell Cycle (Georgetown, Tex.). 8: 430-7. PMID 19176998 DOI: 10.4161/Cc.8.3.7624 |
0.813 |
|
| 2009 |
Li H, Okamoto K, Peart MJ, Prives C. Lysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2A. Molecular and Cellular Biology. 29: 919-928. PMID 18981217 DOI: 10.1128/Mcb.00907-08 |
0.387 |
|
| 2008 |
Prives C, Gottifredi V. The p21 and PCNA partnership: a new twist for an old plot. Cell Cycle. 7: 3840-3846. PMID 19066467 DOI: 10.4161/Cc.7.24.7243 |
0.529 |
|
| 2008 |
Karni-Schmidt O, Zupnick A, Castillo M, Ahmed A, Matos T, Bouvet P, Cordon-Cardo C, Prives C. p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner. Journal of Cell Science. 121: 4098-105. PMID 19033390 DOI: 10.1242/Jcs.030098 |
0.844 |
|
| 2008 |
Soria G, Speroni J, Podhajcer OL, Prives C, Gottifredi V. p21 differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation. Journal of Cell Science. 121: 3271-82. PMID 18782865 DOI: 10.1242/Jcs.027730 |
0.631 |
|
| 2008 |
Prives C, White E. Does control of mutant p53 by Mdm2 complicate cancer therapy? Genes & Development. 22: 1259-64. PMID 18483214 DOI: 10.1101/Gad.1680508 |
0.579 |
|
| 2008 |
Baptiste-Okoh N, Barsotti AM, Prives C. Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent manner. Cell Cycle (Georgetown, Tex.). 7: 1133-8. PMID 18418048 DOI: 10.4161/Cc.7.9.5805 |
0.859 |
|
| 2008 |
Baptiste-Okoh N, Barsotti AM, Prives C. A role for caspase 2 and PIDD in the process of p53-mediated apoptosis. Proceedings of the National Academy of Sciences of the United States of America. 105: 1937-42. PMID 18238895 DOI: 10.1073/Pnas.0711800105 |
0.842 |
|
| 2007 |
Tanaka T, Ohkubo S, Tatsuno I, Prives C. hCAS/CSE1L Associates with Chromatin and Regulates Expression of Select p53 Target Genes Cell. 130: 638-650. PMID 17719542 DOI: 10.1016/J.Cell.2007.08.001 |
0.559 |
|
| 2007 |
Kass EM, Ahn J, Tanaka T, Freed-Pastor WA, Keezer S, Prives C. Stability of checkpoint kinase 2 is regulated via phosphorylation at serine 456. The Journal of Biological Chemistry. 282: 30311-21. PMID 17715138 DOI: 10.1074/Jbc.M704642200 |
0.792 |
|
| 2007 |
Li Y, Prives C. Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function Oncogene. 26: 2220-2225. PMID 17401431 DOI: 10.1038/Sj.Onc.1210311 |
0.6 |
|
| 2007 |
Karni-Schmidt O, Friedler A, Zupnick A, McKinney K, Mattia M, Beckerman R, Bouvet P, Sheetz M, Fersht A, Prives C. Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus. Oncogene. 26: 3878-91. PMID 17237827 DOI: 10.1038/Sj.Onc.1210162 |
0.838 |
|
| 2007 |
Poyurovsky MV, Priest C, Kentsis A, Borden KLB, Pan ZQ, Pavletich N, Prives C. The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity Embo Journal. 26: 90-101. PMID 17170710 DOI: 10.1038/Sj.Emboj.7601465 |
0.725 |
|
| 2007 |
Lokshin M, Li Y, Gaiddon C, Prives C. p53 and p73 display common and distinct requirements for sequence specific binding to DNA. Nucleic Acids Research. 35: 340-52. PMID 17170001 DOI: 10.1093/Nar/Gkl1047 |
0.773 |
|
| 2007 |
Mattia M, Gottifredi V, McKinney K, Prives C. p53-Dependent p21 mRNA elongation is impaired when DNA replication is stalled. Molecular and Cellular Biology. 27: 1309-20. PMID 17158927 DOI: 10.1128/Mcb.01520-06 |
0.86 |
|
| 2006 |
Peart MJ, Prives C. Mutant p53 gain of function: The NF-Y connection Cancer Cell. 10: 173-174. PMID 16959607 DOI: 10.1016/J.Ccr.2006.08.014 |
0.559 |
|
| 2006 |
Braithwaite AW, Prives CL. p53: More research and more questions Cell Death and Differentiation. 13: 877-880. PMID 16708075 DOI: 10.1038/Sj.Cdd.4401938 |
0.451 |
|
| 2006 |
Zupnick AE, Prives C. Mutational Analysis of the p53 Core Domain L1 Loop Journal of Biological Chemistry. 281: 20464-20473. PMID 16687402 DOI: 10.1074/Jbc.M603387200 |
0.856 |
|
| 2006 |
Ohkubo S, Tanaka T, Taya Y, Kitazato K, Prives C. Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription. Journal of Biological Chemistry. 281: 16943-16950. PMID 16624812 DOI: 10.1074/Jbc.M601388200 |
0.651 |
|
| 2006 |
Laptenko O, Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death & Differentiation. 13: 951-961. PMID 16575405 DOI: 10.1038/Sj.Cdd.4401916 |
0.593 |
|
| 2006 |
Poyurovsky MV, Prives C. Unleashing the power of p53: lessons from mice and men. Genes & Development. 20: 125-31. PMID 16418478 DOI: 10.1101/Gad.1397506 |
0.575 |
|
| 2006 |
Soria G, Podhajcer O, Prives C, Gottifredi V. P21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation. Oncogene. 25: 2829-38. PMID 16407842 DOI: 10.1038/Sj.Onc.1209315 |
0.593 |
|
| 2006 |
Feng Z, Jin S, Zupnick A, Hoh J, de Stanchina E, Lowe S, Prives C, Levine AJ. p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene. 25: 1-7. PMID 16278683 DOI: 10.1038/Sj.Onc.1209021 |
0.869 |
|
| 2006 |
Prives C, Tanaka T, Baptiste-Okoh N, Zupnick A. 232 INVITED Transcriptional regulation of apoptosis by the p53 tumor suppressor protein European Journal of Cancer Supplements. 4: 76. DOI: 10.1016/S1359-6349(06)70237-3 |
0.398 |
|
| 2005 |
Lokshin M, Tanaka T, Prives C. Transcriptional regulation by p53 and p73. Cold Spring Harbor Symposia On Quantitative Biology. 70: 121-8. PMID 16869745 DOI: 10.1101/Sqb.2005.70.046 |
0.8 |
|
| 2005 |
Desgranges ZP, Ahn J, Lazebnik MB, Ashworth T, Lee C, Pestell RC, Rosenberg N, Prives C, Roy AL. Inhibition of TFII-I-dependent cell cycle regulation by p53. Molecular and Cellular Biology. 25: 10940-52. PMID 16314517 DOI: 10.1128/Mcb.25.24.10940-10952.2005 |
0.467 |
|
| 2005 |
Okamoto K, Kashima K, Pereg Y, Ishida M, Yamazaki S, Nota A, Teunisse A, Migliorini D, Kitabayashi I, Marine J, Prives C, Shiloh Y, Jochemsen AG, Taya Y. DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation Molecular and Cellular Biology. 25: 9608-9620. PMID 16227609 DOI: 10.1128/Mcb.25.21.9608-9620.2005 |
0.594 |
|
| 2005 |
Prives C, Manfredi JJ. The continuing saga of p53--more sleepless nights ahead. Molecular Cell. 19: 719-21. PMID 16168367 DOI: 10.1016/J.Molcel.2005.08.024 |
0.572 |
|
| 2005 |
Gottifredi V, Prives C. The S phase checkpoint: when the crowd meets at the fork. Seminars in Cell & Developmental Biology. 16: 355-368. PMID 15840444 DOI: 10.1016/J.Semcdb.2005.02.011 |
0.342 |
|
| 2005 |
Vousden KH, Prives C. P53 and prognosis: new insights and further complexity. Cell. 120: 7-10. PMID 15652475 DOI: 10.1016/J.Cell.2004.12.027 |
0.473 |
|
| 2005 |
McKinney K, Prives C. Regulation of p53 DNA binding 25 Years of P53 Research. 27-51. DOI: 10.1007/978-1-4020-2922-6_2 |
0.838 |
|
| 2004 |
Urist M, Tanaka T, Poyurovsky MV, Prives C. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes & Development. 18: 3041-54. PMID 15601819 DOI: 10.1101/Gad.1221004 |
0.842 |
|
| 2004 |
Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D. Regulation of p53 activity through lysine methylation. Nature. 432: 353-60. PMID 15525938 DOI: 10.1038/Nature03117 |
0.851 |
|
| 2004 |
McKinney K, Mattia M, Gottifredi V, Prives C. p53 linear diffusion along DNA requires its C terminus. Molecular Cell. 16: 413-24. PMID 15525514 DOI: 10.1016/J.Molcel.2004.09.032 |
0.834 |
|
| 2004 |
Ahn J, Urist M, Prives C. The Chk2 protein kinase Dna Repair. 3: 1039-1047. PMID 15279791 DOI: 10.1016/J.Dnarep.2004.03.033 |
0.688 |
|
| 2004 |
Urist M, Prives C. The linchpin? Pin1 meets p73. Cancer Cell. 5: 515-517. PMID 15193253 DOI: 10.1016/J.Ccr.2004.06.001 |
0.792 |
|
| 2004 |
Baptiste N, Prives C. p53 in the cytoplasm: a question of overkill? Cell. 116: 487-489. PMID 14980216 DOI: 10.1016/S0092-8674(04)00164-3 |
0.856 |
|
| 2004 |
Puig P, Capodieci P, Drobnjak M, Verbel D, Prives C, Cordon-Cardo C, Di Como CJ. p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 5642-51. PMID 14654547 |
0.3 |
|
| 2004 |
Gottifredi V, McKinney K, Poyurovsky MV, Prives C. Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block. The Journal of Biological Chemistry. 279: 5802-10. PMID 14597617 DOI: 10.1074/Jbc.M310373200 |
0.873 |
|
| 2003 |
Gonzalez S, Prives C, Cordon-Cardo C. p73alpha regulation by Chk1 in response to DNA damage. Molecular and Cellular Biology. 23: 8161-71. PMID 14585975 DOI: 10.1128/Mcb.23.22.8161-8171.2003 |
0.409 |
|
| 2003 |
Poyurovsky MV, Jacq X, Ma C, Karni-Schmidt O, Parker PJ, Chalfie M, Manley JL, Prives C. Nucleotide binding by the Mdm2 RING domain facilitates Arf-independent Mdm2 nucleolar localization. Molecular Cell. 12: 875-87. PMID 14580339 DOI: 10.1016/S1097-2765(03)00400-3 |
0.837 |
|
| 2003 |
Zhou J, Prives C. Replication of damaged DNA in vitro is blocked by p53. Nucleic Acids Research. 31: 3881-92. PMID 12853603 DOI: 10.1093/Nar/Gkg468 |
0.726 |
|
| 2003 |
Gaiddon C, Lokshin M, Gross I, Levasseur D, Taya Y, Loeffler JP, Prives C. Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73. The Journal of Biological Chemistry. 278: 27421-31. PMID 12676926 DOI: 10.1074/Jbc.M300251200 |
0.749 |
|
| 2003 |
Ahn J, Urist M, Prives C. Questioning the role of checkpoint kinase 2 in the p53 DNA damage response. Journal of Biological Chemistry. 278: 20480-20489. PMID 12654916 DOI: 10.1074/Jbc.M213185200 |
0.782 |
|
| 2002 |
Haupt Y, Robles AI, Prives C, Rotter V. Deconstruction of p53 functions and regulation. Oncogene. 21: 8223-31. PMID 12447685 DOI: 10.1038/Sj.Onc.1206137 |
0.501 |
|
| 2002 |
Ahn J, Prives C. Checkpoint Kinase 2 (Chk2) Monomers or Dimers Phosphorylate Cdc25C after DNA Damage Regardless of Threonine 68 Phosphorylation Journal of Biological Chemistry. 277: 48418-48426. PMID 12386164 DOI: 10.1074/Jbc.M208321200 |
0.344 |
|
| 2002 |
McKinney K, Prives C. Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein. Molecular and Cellular Biology. 22: 6797-808. PMID 12215537 DOI: 10.1128/Mcb.22.19.6797-6808.2002 |
0.852 |
|
| 2002 |
Urist M, Prives C. p53 leans on its siblings. Cancer Cell. 1: 311-313. PMID 12086844 DOI: 10.1016/S1535-6108(02)00064-8 |
0.786 |
|
| 2002 |
Okamoto K, Li H, Jensen MR, Zhang T, Taya Y, Thorgeirsson SS, Prives C. Cyclin G Recruits PP2A to Dephosphorylate Mdm2 Molecular Cell. 9: 761-771. PMID 11983168 DOI: 10.1016/S1097-2765(02)00504-X |
0.521 |
|
| 2002 |
Baptiste N, Friedlander P, Chen X, Prives C. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. Oncogene. 21: 9-21. PMID 11791172 DOI: 10.1038/Sj.Onc.1205015 |
0.868 |
|
| 2001 |
Prives C, Manley JL. Why is p53 acetylated? Cell. 107: 815-8. PMID 11779456 DOI: 10.1016/S0092-8674(01)00619-5 |
0.555 |
|
| 2001 |
Ahn J, Prives C. The C-terminus of p53: the more you learn the less you know. Nature Structural & Molecular Biology. 8: 730-732. PMID 11524665 DOI: 10.1038/Nsb0901-730 |
0.514 |
|
| 2001 |
Gottifredi V, Prives C. Getting p53 Out of the Nucleus Science. 292: 1851-1852. PMID 11397937 DOI: 10.1126/Science.1062238 |
0.513 |
|
| 2001 |
Zhang T, Prives C. Cyclin a-CDK phosphorylation regulates MDM2 protein interactions. Journal of Biological Chemistry. 276: 29702-29710. PMID 11359766 DOI: 10.1074/Jbc.M011326200 |
0.514 |
|
| 2001 |
Gottifredi V, Prives C. P53 and PML: new partners in tumor suppression Trends in Cell Biology. 11: 184-187. PMID 11316590 DOI: 10.1016/S0962-8924(01)01983-3 |
0.546 |
|
| 2001 |
Gaiddon C, Lokshin M, Ahn J, Zhang T, Prives C. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Molecular and Cellular Biology. 21: 1874-87. PMID 11238924 DOI: 10.1128/Mcb.21.5.1874-1887.2001 |
0.793 |
|
| 2001 |
Zhou J, Ahn J, Wilson SH, Prives C. A role for p53 in base excision repair Embo Journal. 20: 914-923. PMID 11179235 DOI: 10.1093/Emboj/20.4.914 |
0.736 |
|
| 2001 |
Gottifredi V, Karni-Schmidt O, Shieh SS, Prives C. p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Molecular and Cellular Biology. 21: 1066-76. PMID 11158294 DOI: 10.1128/Mcb.21.4.1066-1076.2001 |
0.883 |
|
| 2001 |
Gottifredi V, Shieh S, Taya Y, Prives C. p53 accumulates but is functionally impaired when DNA synthesis is blocked. Proceedings of the National Academy of Sciences of the United States of America. 98: 1036-1041. DOI: 10.1073/Pnas.98.3.1036 |
0.602 |
|
| 2000 |
Gottifredi V, Shieh SY, Prives C. Regulation of p53 after different forms of stress and at different cell cycle stages. Cold Spring Harbor Symposia On Quantitative Biology. 65: 483-8. PMID 12760065 DOI: 10.1101/Sqb.2000.65.483 |
0.432 |
|
| 2000 |
Cain C, Miller S, Ahn J, Prives C. The N Terminus of p53 Regulates Its Dissociation from DNA Journal of Biological Chemistry. 275: 39944-39953. PMID 10993878 DOI: 10.1074/Jbc.M002509200 |
0.86 |
|
| 2000 |
Ferbeyre G, De Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW. PML is induced by oncogenic ras and promotes premature senescence Genes and Development. 14: 2015-2027. PMID 10950866 |
0.345 |
|
| 2000 |
Bond GL, Prives C, Manley JL. Poly(A) polymerase phosphorylation is dependent on novel interactions with cyclins. Molecular and Cellular Biology. 20: 5310-20. PMID 10866687 DOI: 10.1128/Mcb.20.14.5310-5320.2000 |
0.355 |
|
| 2000 |
Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, Robertson S, Whittaker K, Demsky M, Fisher WW, Buchman A, Duyk G, Friedman L, Prives C, Kopczynski C. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell. 101: 91-101. PMID 10778859 DOI: 10.1016/S0092-8674(00)80626-1 |
0.601 |
|
| 2000 |
Shieh S, Ahn J, Tamai K, Taya Y, Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites Genes & Development. 14: 289-300. DOI: 10.1101/Gad.14.3.289 |
0.497 |
|
| 2000 |
Ferbeyre G, Stanchina Ed, Querido E, Baptiste N, Prives C, Lowe SW. PML is induced by oncogenic ras and promotes premature senescence Genes & Development. 14: 2015-2027. DOI: 10.1101/Gad.14.16.2015 |
0.823 |
|
| 1999 |
Cordon-Cardo C, Prives C. At the crossroads of inflammation and tumorigenesis. The Journal of Experimental Medicine. 190: 1367-70. PMID 10562311 DOI: 10.1084/Jem.190.10.1367 |
0.341 |
|
| 1999 |
Gaiddon C, Moorthy NC, Prives C. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. The Embo Journal. 18: 5609-21. PMID 10523305 DOI: 10.1093/Emboj/18.20.5609 |
0.66 |
|
| 1999 |
Okamoto K, Prives C. A role of cyclin G in the process of apoptosis. Oncogene. 18: 4606-4615. PMID 10467405 DOI: 10.1038/Sj.Onc.1202821 |
0.459 |
|
| 1999 |
White E, Prives C. DNA damage enables p73. Nature. 399: 734-5, 737. PMID 10391235 DOI: 10.1038/21539 |
0.503 |
|
| 1999 |
Prives C, Hall PA. The p53 pathway. The Journal of Pathology. 187: 112-26. PMID 10341712 DOI: 10.1002/(Sici)1096-9896(199901)187:1<112::Aid-Path250>3.0.Co;2-3 |
0.554 |
|
| 1999 |
Shieh SY, Taya Y, Prives C. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. The Embo Journal. 18: 1815-23. PMID 10202145 DOI: 10.1093/Emboj/18.7.1815 |
0.501 |
|
| 1999 |
Reynisdóttir I, Bhattacharyya S, Zhang D, Prives C. The retinoblastoma protein alters the phosphorylation state of polyomavirus large T antigen in murine cell extracts and inhibits polyomavirus origin DNA replication. Journal of Virology. 73: 3004-3013. PMID 10074150 DOI: 10.1128/Jvi.73.4.3004-3013.1999 |
0.363 |
|
| 1999 |
Jayaraman L, Prives C. Covalent and noncovalent modifiers of the p53 protein. Cellular and Molecular Life Sciences : Cmls. 55: 76-87. PMID 10065153 DOI: 10.1007/s000180050271 |
0.46 |
|
| 1999 |
Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes & Development. 13: 152-7. PMID 9925639 DOI: 10.1101/Gad.13.2.152 |
0.49 |
|
| 1999 |
Como CJD, Gaiddon C, Prives C. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Molecular and Cellular Biology. 19: 1438-1449. PMID 9891077 DOI: 10.1128/Mcb.19.2.1438 |
0.661 |
|
| 1999 |
Campagne MvL, Okamoto K, Prives C, Gill R. Developmental expression and co-localization of cyclin G1 and the B' subunits of protein phosphatase 2a in neurons. Molecular Brain Research. 64: 1-10. PMID 9889295 DOI: 10.1016/S0169-328X(98)00283-6 |
0.311 |
|
| 1999 |
Prikhod'ko GG, Wang Y, Freulich E, Prives C, Miller LK. Baculovirus p33 binds human p53 and enhances p53-mediated apoptosis. Journal of Virology. 73: 1227-34. PMID 9882325 DOI: 10.1128/Jvi.73.2.1227-1234.1999 |
0.609 |
|
| 1998 |
Vassilev A, Yamauchi J, Kotani T, Prives C, Avantaggiati ML, Qin J, Nakatani Y. The 400 kDa Subunit of the PCAF Histone Acetylase Complex Belongs to the ATM Superfamily Molecular Cell. 2: 869-875. PMID 9885574 DOI: 10.1016/S1097-2765(00)80301-9 |
0.459 |
|
| 1998 |
Prives C. Signaling To P53 : Breaking The Mdm2-P53 Circuit Cell. 95: 5-8. PMID 9778240 DOI: 10.1016/S0092-8674(00)81774-2 |
0.589 |
|
| 1998 |
Banin S, Moyal L, Shieh SY, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage Science. 281: 1674-1677. PMID 9733514 DOI: 10.1126/science.281.5383.1674 |
0.338 |
|
| 1998 |
de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes & Development. 12: 2434-42. PMID 9694807 DOI: 10.1101/Gad.12.15.2434 |
0.631 |
|
| 1998 |
Como CJD, Prives C. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay. Oncogene. 16: 2527-2539. PMID 9627118 DOI: 10.1038/Sj.Onc.1202041 |
0.555 |
|
| 1998 |
Jayaraman L, Moorthy NC, Murthy KG, Manley JL, Bustin M, Prives C. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes & Development. 12: 462-72. PMID 9472015 DOI: 10.1101/Gad.12.4.462 |
0.58 |
|
| 1998 |
Colgan DF, Murthy KG, Zhao W, Prives C, Manley JL. Inhibition of poly(A) polymerase requires p34cdc2/cyclin B phosphorylation of multiple consensus and non-consensus sites. The Embo Journal. 17: 1053-62. PMID 9463383 DOI: 10.1093/Emboj/17.4.1053 |
0.35 |
|
| 1998 |
Niculescu AB, Chen X, Smeets M, Hengst L, Prives C, Reed SI. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Molecular and Cellular Biology. 18: 629-43. PMID 9418909 DOI: 10.1128/Mcb.18.1.629 |
0.552 |
|
| 1997 |
Ko LJ, Shieh SY, Chen X, Jayaraman L, Tamai K, Taya Y, Prives C, Pan ZQ. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Molecular and Cellular Biology. 17: 7220-9. PMID 9372954 DOI: 10.1128/Mcb.17.12.7220 |
0.572 |
|
| 1997 |
Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell. 91: 325-34. PMID 9363941 DOI: 10.1016/S0092-8674(00)80416-X |
0.56 |
|
| 1997 |
Jayaraman L, Freulich E, Prives C. Functional dissection of p53 tumor suppressor protein Methods in Enzymology. 283: 245-256. PMID 9251024 DOI: 10.1016/S0076-6879(97)83020-0 |
0.631 |
|
| 1997 |
Miller SD, Moses K, Jayaraman L, Prives C. Complex formation between p53 and replication protein A inhibits the sequence-specific DNA binding of p53 and is regulated by single-stranded DNA. Molecular and Cellular Biology. 17: 2194-201. PMID 9121469 DOI: 10.1128/Mcb.17.4.2194 |
0.531 |
|
| 1997 |
Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes & Development. 11: 558-70. PMID 9119221 DOI: 10.1101/Gad.11.5.558 |
0.63 |
|
| 1996 |
Oren M, Prives C. p53: Upstream, downstream and off stream. Review of the 8th p53 workshop (Dundee, July 5-9, 1996) Biochimica Et Biophysica Acta - Reviews On Cancer. 1288. PMID 9011182 DOI: 10.1016/S0304-419X(96)00030-3 |
0.534 |
|
| 1996 |
Farmer G, Friedlander P, Colgan J, Manley JL, Prives C. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein. Nucleic Acids Research. 24: 4281-8. PMID 8932384 DOI: 10.1093/Nar/24.21.4281 |
0.59 |
|
| 1996 |
Colgan DF, Murthy KG, Prives C, Manley JL. Cell-cycle related regulation of poly(A) polymerase by phosphorylation. Nature. 384: 282-5. PMID 8918882 DOI: 10.1038/384282A0 |
0.391 |
|
| 1996 |
Chen X, Ko LJ, Jayaraman L, Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes & Development. 10: 2438-51. PMID 8843196 DOI: 10.1101/Gad.10.19.2438 |
0.638 |
|
| 1996 |
Friedlander P, Legros Y, Soussi T, Prives C. Regulation of Mutant p53 Temperature-sensitive DNA Binding Journal of Biological Chemistry. 271: 25468-25478. PMID 8810317 DOI: 10.1074/Jbc.271.41.25468 |
0.563 |
|
| 1996 |
Friedlander P, Haupt Y, Prives C, Oren M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis Molecular and Cellular Biology. 16: 4961-4971. PMID 8756655 DOI: 10.1128/Mcb.16.9.4961 |
0.606 |
|
| 1996 |
Farmer G, Colgan J, Nakatani Y, Manley JL, Prives C. Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo. Molecular and Cellular Biology. 16: 4295-304. PMID 8754830 DOI: 10.1128/Mcb.16.8.4295 |
0.543 |
|
| 1996 |
Ko LJ, Prives C. p53: Puzzle and paradigm Genes and Development. 10: 1054-1072. PMID 8654922 DOI: 10.1101/GAD.10.9.1054 |
0.497 |
|
| 1995 |
Miller SD, Farmer G, Prives C. p53 Inhibits DNA replication in vitro in a DNA-binding-dependent manner Molecular and Cellular Biology. 15: 6554-6560. PMID 8524220 DOI: 10.1128/Mcb.15.12.6554 |
0.608 |
|
| 1995 |
Truant R, Antunovic J, Greenblatt J, Prives C, Cromlish JA. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. Journal of Virology. 69: 1851-9. PMID 7853526 DOI: 10.1128/JVI.69.3.1851-1859.1995 |
0.557 |
|
| 1995 |
Jayaraman J, Prives C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell. 81: 1021-9. PMID 7600571 DOI: 10.1016/S0092-8674(05)80007-8 |
0.601 |
|
| 1995 |
Wang Y, Prives C. Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases Nature. 376: 88-91. PMID 7596441 DOI: 10.1038/376088A0 |
0.586 |
|
| 1994 |
Moses K, Prives C. A unique subpopulation of murine DNA polymerase α/primase specifically interacts with polyomavirus T antigen and stimulates DNA replication Molecular and Cellular Biology. 14: 2767-2776. PMID 8139575 DOI: 10.1128/Mcb.14.4.2767 |
0.331 |
|
| 1994 |
Prives C. How loops, β sheets, and α helices help us to understand p53 Cell. 78: 543-546. PMID 8069906 DOI: 10.1016/0092-8674(94)90519-3 |
0.336 |
|
| 1994 |
Prives C, Bargonetti J, Farmer G, Ferrari E, Friedlander P, Wang Y, Jayaraman L, Pavletich N, Hubscher U. DNA-binding properties of the p53 tumor suppressor protein Cold Spring Harbor Symposia On Quantitative Biology. 59: 207-213. PMID 7587071 DOI: 10.1101/Sqb.1994.059.01.025 |
0.51 |
|
| 1993 |
Prives C. Doing the right thing: feedback control and p53 Current Opinion in Cell Biology. 5: 214-218. PMID 8507493 DOI: 10.1016/0955-0674(93)90105-Y |
0.609 |
|
| 1993 |
Friedman PN, Chen X, Bargonetti J, Prives C. The p53 protein is an unusually shaped tetramer that binds directly to DNA Proceedings of the National Academy of Sciences of the United States of America. 90: 3319-3323. PMID 8475074 DOI: 10.1073/Pnas.90.8.3319 |
0.591 |
|
| 1993 |
Wang EH, Bhattacharyya S, Prives C. The replication functions of polyomavirus large tumor antigen are regulated by phosphorylation. Journal of Virology. 67: 6788-6796. PMID 8411381 DOI: 10.1128/Jvi.67.11.6788-6796.1993 |
0.332 |
|
| 1993 |
Chen X, Farmer G, Zhu H, Prywes R, Prives C. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. Genes & Development. 7: 1837-49. PMID 8405994 DOI: 10.1101/Gad.7.10.1837 |
0.61 |
|
| 1993 |
Lorimer HE, Reynisdöttir I, Ness S, Prives C. Unusual Properties of a Replication-Defective Mutant SV40 Large T Antigen Virology. 192: 402-414. PMID 8380658 DOI: 10.1006/Viro.1993.1055 |
0.3 |
|
| 1993 |
Bargonetti J, Manfredi JJ, Chen X, Marshak DR, Prives C. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein Genes and Development. 7: 2565-2574. PMID 8276239 DOI: 10.1101/Gad.7.12B.2565 |
0.553 |
|
| 1993 |
Prives C, Manfredi JJ. The p53 tumor suppressor protein: meeting review. Genes & Development. 7: 529-534. PMID 8096197 DOI: 10.1101/Gad.7.4.529 |
0.454 |
|
| 1993 |
Friedman PN, Wang EH, Meerovitch K, Sonenberg N, Prives C. Murine p53 inhibits the function but not the formation of SV40 T antigen hexamers and stimulates T antigen RNA helicase activity. Chromosoma. 102: S60-6. PMID 1337881 DOI: 10.1007/Bf02451787 |
0.447 |
|
| 1992 |
Zambetti GP, Bargonetti J, Walker K, Prives C, Levine AJ. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element Genes and Development. 6: 1143-1152. PMID 1628822 DOI: 10.1101/Gad.6.7.1143 |
0.575 |
|
| 1992 |
Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C. Wild-type p53 activates transcription in vitro. Nature. 358: 83-6. PMID 1614538 DOI: 10.1038/358083A0 |
0.596 |
|
| 1992 |
Bargonetti J, Reynisdottir I, Friedman PN, Prives C. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53 Genes and Development. 6: 1886-1898. PMID 1398068 DOI: 10.1101/Gad.6.10.1886 |
0.565 |
|
| 1991 |
Friedman PN, Kern SE, Vogelstein B, Prives C. Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen. Proceedings of the National Academy of Sciences of the United States of America. 87: 9275-9. PMID 2174557 DOI: 10.1073/Pnas.87.23.9275 |
0.587 |
|
| 1991 |
Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B. Identification of p53 as a sequence-specific DNA-binding protein. Science (New York, N.Y.). 252: 1708-11. PMID 2047879 DOI: 10.1126/Science.2047879 |
0.426 |
|
| 1991 |
Lorimer HE, Wang EH, Prives C. The DNA-binding properties of polyomavirus large T antigen are altered by ATP and other nucleotides Journal of Virology. 65: 687-699. PMID 1846192 DOI: 10.1128/Jvi.65.2.687-699.1991 |
0.356 |
|
| 1991 |
Prives C, Bargonetti J, Friedman PN, Manfredi JJ, Wang EH. Functional consequences of the interactions of the p53 tumor suppressor protein and SV40 large tumor antigen Cold Spring Harbor Symposia On Quantitative Biology. 56: 227-235. PMID 1668081 DOI: 10.1101/Sqb.1991.056.01.028 |
0.39 |
|
| 1991 |
Bargonetti J, Friedman PN, Kern SE, Vogelstein B, Prives C. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication Cell. 65: 1083-1091. PMID 1646078 DOI: 10.1016/0092-8674(91)90560-L |
0.569 |
|
| 1990 |
Reynisdóttir I, O'Reilly DR, Miller LK, Prives C. Thermally inactivated simian virus 40 tsA58 mutant T antigen cannot initiate viral DNA replication in vitro. Journal of Virology. 64: 6234-6245. PMID 2173789 DOI: 10.1128/Jvi.64.12.6234-6245.1990 |
0.332 |
|
| 1990 |
Bischoff JR, Friedman PN, Marshak DR, Prives C, Beach D. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proceedings of the National Academy of Sciences of the United States of America. 87: 4766-70. PMID 2141171 DOI: 10.1073/PNAS.87.12.4766 |
0.448 |
|
| 1989 |
Pan Z, Prives C. U2 snRNA sequences that bind U2-specific proteins are dispensable for the function of U2 snRNP in splicing. Genes & Development. 3: 1887-1898. PMID 2559872 DOI: 10.1101/Gad.3.12A.1887 |
0.304 |
|
| 1989 |
Wang EH, Friedman PN, Prives C. The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen Cell. 57: 379-392. PMID 2541911 DOI: 10.1016/0092-8674(89)90913-6 |
0.55 |
|
| 1988 |
Auborn KJ, Markowitz RB, Wang E, Yu YT, Prives C. Simian virus 40 (SV40) T antigen binds specifically to double-stranded DNA but not to single-stranded DNA or DNA/RNA hybrids containing the SV40 regulatory sequences. Journal of Virology. 62: 2204-8. PMID 3367427 DOI: 10.1128/Jvi.62.6.2204-2208.1988 |
0.345 |
|
| 1987 |
Michaeli T, Prives C. pBR322 DNA inhibits simian virus 40 gene expression in Xenopus laevis oocytes. Nucleic Acids Research. 15: 1579-94. PMID 3029720 DOI: 10.1093/Nar/15.4.1579 |
0.367 |
|
| 1987 |
Prives C, Murakami Y, Kern FG, Folk W, Basilico C, Hurwitz J. DNA sequence requirements for replication of polyomavirus DNA in vivo and in vitro Molecular and Cellular Biology. 7: 3694-3704. PMID 2824994 DOI: 10.1128/Mcb.7.10.3694 |
0.382 |
|
| 1986 |
Bolen JB, Cary K, Scheller A, Basilico C, Israel MA, Prives C. A subclass of polyomavirus middle tumor antigen binds to DNA cellulose Journal of Virology. 58: 157-164. PMID 3005644 DOI: 10.1128/Jvi.58.1.157-164.1986 |
0.33 |
|
| 1984 |
Prives C, Covey L, Scheller A, Gluzman Y. DNA-binding properties of simian virus 40 T-antigen mutants defective in viral DNA replication. Molecular and Cellular Biology. 3: 1958-66. PMID 6318076 DOI: 10.1128/Mcb.3.11.1958 |
0.317 |
|
| 1984 |
Fradin A, Jove R, Hemenway C, Keiser HD, Manley JL, Prives C. Splicing pathways of SV40 mRNAs in X. laevis oocytes differ in their requirements for snRNPs. Cell. 37: 927-36. PMID 6086149 DOI: 10.1016/0092-8674(84)90427-6 |
0.303 |
|
| 1984 |
Prives C. Advances in Viral Oncology. Volume 2: The Transformation-Associated Cellular p53 Protein.George Klein The Quarterly Review of Biology. 59: 62-63. DOI: 10.1086/413688 |
0.307 |
|
| 1983 |
May E, Lasne C, Prives C, Borde J, May P. Study of the Functional Activities Concomitantly Retained by the 115,000 Mr Super T Antigen, an Evolutionary Variant of Simian Virus 40 Large T Antigen Expressed in Transformed Rat Cells Journal of Virology. 45: 901-913. PMID 6300461 DOI: 10.1128/Jvi.45.3.901-913.1983 |
0.377 |
|
| 1982 |
Fradin A, Manley JL, Prives CL. Methylation of simian virus 40 Hpa II site affects late, but not early, viral gene expression. Proceedings of the National Academy of Sciences of the United States of America. 79: 5142-6. PMID 6291026 DOI: 10.1073/Pnas.79.17.5142 |
0.334 |
|
| 1982 |
Scheller A, Covey L, Barnet B, Prives C. A small subclass of SV40 T antigen binds to the viral origin of replication. Cell. 29: 375-83. PMID 6288256 DOI: 10.1016/0092-8674(82)90154-4 |
0.317 |
|
| 1982 |
Prives C, Barnet B, Scheller A, Khoury G, Jay G. Discrete regions of simian virus 40 large T antigen are required for nonspecific and viral origin-specific DNA binding. Journal of Virology. 43: 73-82. PMID 6287017 DOI: 10.1128/Jvi.43.1.73-82.1982 |
0.31 |
|
| 1982 |
Gidoni D, Scheller A, Barnet B, Hantzopoulos P, Oren M, Prives C. Different forms of simian virus 40 large tumor antigen varying in their affinities for DNA. Journal of Virology. 42: 456-466. DOI: 10.1128/Jvi.42.2.456-466.1982 |
0.303 |
|
| 1981 |
Prives C, Beck Y, Gidoni D, Oren M, Shure H. DNA binding and sedimentation properties of SV40 T antigens synthesized in vivo and in vitro. Cold Spring Harbor Symposia On Quantitative Biology. 123-30. PMID 6253125 DOI: 10.1101/Sqb.1980.044.01.014 |
0.314 |
|
| 1980 |
Prives C, Beck Y, Shure H. DNA binding properties of simian virus 40 T-antigens synthesized in vivo and in vitro. Journal of Virology. 33: 689-696. PMID 6251241 DOI: 10.1128/Jvi.33.2.689-696.1980 |
0.311 |
|
| 1980 |
Oren M, Winocour E, Prives C. Differential affinities of simian virus 40 large tumor antigen for DNA. Proceedings of the National Academy of Sciences of the United States of America. 77: 220-4. PMID 6244545 DOI: 10.1073/Pnas.77.1.220 |
0.329 |
|
| 1969 |
Prives C, Quastel JH. Effect of cerebral stimulation on biosynthesis of nucleotides and RNA in brain slices in vitro Bba Section Nucleic Acids and Protein Synthesis. 182: 285-294. PMID 5795481 DOI: 10.1016/0005-2787(69)90179-8 |
0.397 |
|
| 1969 |
Prives C, Quastel JH. Effects of cerebral stimulation on the biosynthesis in vitro of nucleotides and RNA in brain [15] Nature. 221: 1053. DOI: 10.1038/2211053a0 |
0.388 |
|
| Show low-probability matches. |
